Breaking News

Recipharm Secures Vaccine Manufacturing Deal

Inks deal with top 10 big pharma and will provide manufacturing support from facility in Kaysersberg, France.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Global contract development and manufacturing organization (CDMO), Recipharm, has inked a deal with a top 10 big pharma company to support vaccine manufacturing from its facility in Kaysersberg, France. The agreement was announced following the successful quality audit and will see Recipharm aseptically pack single-use vaccines, used to treat a severe infectious disease that affects both young children and infants. The containers will be filled using Recipharm’s blow-fill-seal (BFS) capabi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters